NEW YORK (GenomeWeb News) – Bruker and Chungnam National University in South Korea announced today a collaboration to develop MALDI-TOF-based methodologies for the analysis of glycans.
The deal between Bruker and the Graduate School of Analytical Science and Technology at the university will be targeted mainly at creating methods and software applications in the development and quality control of biologics, such as therapeutic antibodies, they said.
The partnership will also serve as an Asia Glycomics Reference Site and provide support to the wider Asian Glycomics community, they added. The work is expected to "create a better understanding of the function of glycans in biomolecules and their key role in many biological processes."
Financial and other terms of the deal were not disclosed.
The research will be led by Hyun Joo An, a professor at the university, and Detlev Suckau at Bruker.
"The potential we see, particularly for the biosimilar industry, indicates that glycan research will continue to increase in importance, particularly as workflows develop to unravel its complexities," An said in a statement.